Biogen to study Spinraza in combination with $2-mn Novartis drug
The one-a-day oral drug is viewed as a potential a rival to Spinraza, which is administered every four months via spinal infusion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
gene therapy
Noga Therapeutics and Lonza to develop Autologous Lentiviral Gene Therapy on the Cocoon Platform
The Cocoon Platform is a closed, highly customizable and scalable platform with minimal touchpoints, which will help Noga…
Merck boosts commercial viral vector and gene therapy manufacturing capacity
The new, € 100 million commercial facility is expected to open next year
Merck acquires FloDesign Sonics, of Wilbraham, Massachusetts, USA
The acquisition is strategic fit for Merck, strengthening ability alongside pharmaceutical manufacturers to advance cell-based…